Gionata Fiorino

Gionata Fiorino

UNVERIFIED PROFILE

Are you Gionata Fiorino?   Register this Author

Register author
Gionata Fiorino

Gionata Fiorino

Publications by authors named "Gionata Fiorino"

Are you Gionata Fiorino?   Register this Author

100Publications

1682Reads

-Profile Views

Detection and management of early stage inflammatory bowel disease: an update for clinicians.

Expert Rev Gastroenterol Hepatol 2019 Jun 22;13(6):547-555. Epub 2019 Apr 22.

a IBD Center, Department of Gastroenterology , Humanitas Research Hospital , Rozzano, Milan , Italy.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/17474124.2019.1
Publisher Site
http://dx.doi.org/10.1080/17474124.2019.1605291DOI Listing
June 2019

Effectiveness of Infliximab Biosimilar in Crohn's Disease: A Dime, A Dozen.

Gastroenterology 2019 Jun 26;156(8):2349-2351. Epub 2019 Apr 26.

IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center, Rozzano and Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2019.04.029DOI Listing
June 2019

Vedolizumab for the treatment of inflammatory bowel diseases: from symptomatic control to mucosal healing.

Immunotherapy 2019 May 12;11(7):565-575. Epub 2019 Mar 12.

Department of Gastroenterology, IBD Center, Humanitas Clinical & Research Center, 20089, Milan, Italy.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/imt-2018-0209
Publisher Site
http://dx.doi.org/10.2217/imt-2018-0209DOI Listing
May 2019

Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).

Dig Liver Dis 2019 May 19;51(5):632-639. Epub 2019 Feb 19.

IBD Unit, Presidio Columbus, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Università Cattolica del Sacro Cuore, Rome, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2019.02.004DOI Listing
May 2019

Anti-TNF Biosimilars in Inflammatory Bowel Disease: Searching the Proper Patient's Profile.

Curr Med Chem 2019 ;26(2):280-287

IBD Center, Department of Gastroenterology, Humanitas Research Hospital, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/0929867325666180514100204DOI Listing
April 2019

Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective study.

Dig Liver Dis 2019 04 28;51(4):510-515. Epub 2018 Oct 28.

Clinical Unit for Chronic Bowel Disorders, Dept. of Clinical and Experimental Medicine, University of Messina, Messina, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2018.10.013DOI Listing
April 2019

Noninvasive Multimodal Methods to Differentiate Inflamed vs Fibrotic Strictures in Patients With Crohn's Disease.

Clin Gastroenterol Hepatol 2019 Apr 14. Epub 2019 Apr 14.

Inflammatory Bowel Disease Centre, Humanitas Clinical and Research Centre, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2019.04.025DOI Listing
April 2019

Anti-fibrotic drugs for Crohn's disease: Ready for prime time?

Curr Pharm Des 2019 Mar 7. Epub 2019 Mar 7.

IBD Centre, Humanitas Clinical and Research Centre, Rozzano, Milan. Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1381612825666190308100844DOI Listing
March 2019

Biosimilars of adalimumab in IBD: are we ready for that?

Curr Pharm Des 2019 Mar 11. Epub 2019 Mar 11.

IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Institute, Rozzano, Milan. Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1381612825666190312113610DOI Listing
March 2019

'Quality of Care' Standards in Inflammatory Bowel Disease: A Systematic Review.

J Crohns Colitis 2019 Jan;13(1):127-137

Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ecco-jcc/jjy140DOI Listing
January 2019

Biosimilars of adalimumab: the upcoming challenge in IBD.

Expert Opin Biol Ther 2019 Jan 2. Epub 2019 Jan 2.

a IBD Center, Department of Gastroenterology , Humanitas Clinical and Research Institute , Rozzano, Milan , Italy.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14712598.2019.1
Publisher Site
http://dx.doi.org/10.1080/14712598.2019.1564033DOI Listing
January 2019

JAK inhibitors: Novel developments in management of ulcerative colitis.

Best Pract Res Clin Gastroenterol 2018 Feb - Apr;32-33:89-93. Epub 2018 May 23.

Humanitas University, Department of Biomedical Sciences, Rozzano, Milan, Italy; Humanitas Clinical and Research Institute, IBD Center, Rozzano, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15216918183005
Publisher Site
http://dx.doi.org/10.1016/j.bpg.2018.05.015DOI Listing
September 2018

Can IL-23 be a good target for ulcerative colitis?

Best Pract Res Clin Gastroenterol 2018 Feb - Apr;32-33:95-102. Epub 2018 May 23.

IBD Centre, Humanitas Clinical and Research Centre, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bpg.2018.05.016DOI Listing
September 2018

Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's Disease.

Gastroenterology 2018 07 28;155(1):76-87. Epub 2018 Mar 28.

Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2018.03.032DOI Listing
July 2018

Janus kinase inhibitors for the treatment of inflammatory bowel diseases: developments from phase I and phase II clinical trials.

Expert Opin Investig Drugs 2018 07 6;27(7):595-599. Epub 2018 Jul 6.

a Department of Biomedical Sciences , Humanitas University , Milan , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13543784.2018.1492547DOI Listing
July 2018

PF-00547659 for the treatment of Crohn's disease and ulcerative colitis.

Expert Opin Investig Drugs 2018 Jul 16;27(7):623-629. Epub 2018 Jul 16.

a IBD Centre, Humanitas Clinical and Research Centre , Milan , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13543784.2018.1494722DOI Listing
July 2018

Sexual and reproductive issues and inflammatory bowel disease: a neglected topic in men.

Eur J Gastroenterol Hepatol 2018 Mar;30(3):316-322

IBD Centre, Humanitas Clinical and Research Centre.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MEG.0000000000001074DOI Listing
March 2018

Vedolizumab for the treatment of Crohn's disease.

Expert Rev Clin Immunol 2018 03 23;14(3):179-189. Epub 2018 Feb 23.

b IBD Center, Department of Gastroenterology , Humanitas Research Hospital , Milan , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/1744666X.2018.1438189DOI Listing
March 2018

Biologic Therapies in Ulcerative Colitis: Primi Inter Pares?

Curr Drug Targets 2018 ;19(7):748-756

IBD Center, Gastroenterology, IRCCS Humanitas, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1389450117666160527142719DOI Listing
January 2018

Personalizing Psychological Treatment Along the IBD Journey: From Diagnosis to Surgery.

Curr Drug Targets 2018 ;19(7):722-728

Department of Health Sciences, Universita degli Studi di Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1389450118666170502142939DOI Listing
January 2018

Novel therapeutic targets for inflammatory bowel disease.

J Autoimmun 2017 Dec 12;85:103-116. Epub 2017 Jul 12.

IBD Center, Department of Gastroenterology, Humanitas Research Hospital, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaut.2017.07.004DOI Listing
December 2017

Early intervention in Crohn's disease: towards disease modification trials.

Gut 2017 12 5;66(12):2179-2187. Epub 2017 Sep 5.

Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/gutjnl-2017-314519DOI Listing
December 2017

Comparison of two methods for the in-vivo diagnosis of Helicobacter pylori infection using a tablet of 13C-urea.

Minerva Gastroenterol Dietol 2017 Dec;63(4):319-326

IBD Center, Humanitas Clinical and Research Center, Rozzano, Milan, Italy -

View Article

Download full-text PDF

Source
http://dx.doi.org/10.23736/S1121-421X.17.02411-4DOI Listing
December 2017

Biosimilar Drugs for Inflammatory Bowel Disease: Is Similar Good Enough?

Dig Dis Sci 2017 11;62(11):2964-2965

Division of Gastroenterology, IBD Center, IRCCS Istituto Clinico Humanitas ICH, 20089, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10620-017-4693-9DOI Listing
November 2017

MFSD2A Promotes Endothelial Generation of Inflammation-Resolving Lipid Mediators and Reduces Colitis in Mice.

Gastroenterology 2017 11 4;153(5):1363-1377.e6. Epub 2017 Aug 4.

IBD Center, Laboratory of Gastrointestinal Immunopathology, Humanitas Clinical and Research Center, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2017.07.048DOI Listing
November 2017

Efficacy of tumour necrosis factor antagonists in stricturing Crohn's disease: A tertiary center real-life experience.

Dig Liver Dis 2017 Aug 30;49(8):872-877. Epub 2017 Mar 30.

IBD Center, Gastroenterology, IRCCS Humanitas, Rozzano, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2017.03.012DOI Listing
August 2017

Filgotinib in Crohn's Disease: JAK Is Back.

Gastroenterology 2017 Aug 24;153(2):603-605. Epub 2017 Jun 24.

Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2017.06.040DOI Listing
August 2017

IL-23 Blockade for Crohn s disease: next generation of anti-cytokine therapy.

Expert Rev Clin Immunol 2017 05 13;13(5):457-467. Epub 2017 Jan 13.

a IBD Center, Department of Gastroenterology , Humanitas Research Hospital , Rozzano , Milan , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/1744666X.2017.1279055DOI Listing
May 2017

The safety of biological pharmacotherapy for the treatment of ulcerative colitis.

Expert Opin Drug Saf 2017 Apr 10;16(4):437-443. Epub 2017 Mar 10.

a IBD Center, Department of Gastroenterology , Humanitas Research Hospital , Milan , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14740338.2017.1298743DOI Listing
April 2017

The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar.

Inflamm Bowel Dis 2017 02;23(2):233-243

1IBD Center, Department of Gastroenterology, Humanitas Research Hospital, Humanitas University, Rozzano, Italy; 2Department of Gastroenterology, AOU Careggi, Florence, Italy; 3IBD Unit, Complesso Integrato Columbus-Gemelli Hospital Catholic University Foundation, Rome, Italy; 4Department of Internal Medicine 2, IBD Unit, Riuniti Villa Sofia-Cervello Hospital, Palermo, Italy; 5Unit of Gastroenterology, Centro Malattie Retto-Intestinali, Sacro Cuore Don Calabria Hospital, Negrar, Italy; 6Gastroenterology Unit, IRCCS-CSS Hospital, San Giovanni Rotondo, Italy; 7Gastroenterology and IBD Unit, Luigi Sacco University Hospital, Milan, Italy; 8Unit of Gastroenterology, University of Padova, Padova, Italy; 9Department of Gastroenterology and Nutrition, Meyer Children's Hospital, Florence, Italy; 10Unit of Gastroenterology, S. Camillo-Forlanini Hospital, Rome, Italy; 11Clinical Unit for Chronic Bowel Disorders, University of Messina, Messina, Italy; 12Department of Gastroenterology, IRCCS Policlinico, San Donato Milanese-Milano, Italy; 13Unit of Gastroenterology, AOUP, Pisa, Italy; 14Department of Gastroenterology and Endoscopy, AO Hospital, Legnano, Italy; 15Department of Systems Medicine, Gastroenterology, University of Rome Tor Vergata, Roma, Italy; 16Unit of Gastroenterology, AOU di Circolo Fondazione Macchi, Varese, Italy; 17Department of Gastroenterology, Ospedale Valduce, Como, Italy; and 18Department of Gastroenterology, Fatebenefratelli-Oftalmico Hospital, Milano, Italy.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/ibdjournal/2017/02000/The_PROSI
Web Search
http://dx.doi.org/10.1097/MIB.0000000000000995DOI Listing
February 2017

ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease-An Update.

J Crohns Colitis 2017 Jan 7;11(1):26-34. Epub 2016 Dec 7.

ECCO Governing Board; Gastroenterology and Inserm U954, University Hospital of Nancy, Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ecco-jcc/jjw198DOI Listing
January 2017

The Experience with Biosimilars of Infliximab in Inflammatory Bowel Disease.

Curr Pharm Des 2017 ;23(44):6759-6769

IBD Center, Dept. of Gastroenterology, Humanitas Clinical and Research Institute, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1381612824666171204095342DOI Listing
January 2017

Biosimilar therapies in inflammatory bowel disease: should we care about patient profile?

Expert Rev Clin Immunol 2016 8;12(4):361-3. Epub 2016 Feb 8.

c Department of Biomedical Sciences , Humanitas University , Rozzano, Milan , Italy.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/1744666X.2016.11
Publisher Site
http://dx.doi.org/10.1586/1744666X.2016.1141050DOI Listing
December 2016

Diagnostic Delay in Crohn's Disease: Time for Red Flags.

Dig Dis Sci 2016 11 16;61(11):3097-3098. Epub 2016 Sep 16.

Department of Gastroenterology, IBD Center, Humanitas Research Hospital, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10620-016-4298-8DOI Listing
November 2016

Changes in Biosimilar Knowledge among European Crohn's Colitis Organization [ECCO] Members: An Updated Survey.

J Crohns Colitis 2016 Nov 25;10(11):1362-1365. Epub 2016 Apr 25.

Gastro-entérologie La Source-Beaulieu, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ecco-jcc/jjw090DOI Listing
November 2016

Adalimumab and Azathioprine Combination Therapy for Crohn's Disease: A Shining Diamond?

J Crohns Colitis 2016 Nov 7;10(11):1257-1258. Epub 2016 Jul 7.

Department of Gastroenterology, Humanitas Research Hospital, Rozzano, Milan, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ecco-jcc/jjw119DOI Listing
November 2016

Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis.

Clin Gastroenterol Hepatol 2016 10 14;14(10):1385-1397.e10. Epub 2016 May 14.

Department of Biomedical Sciences, Humanitas University, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2016.04.039DOI Listing
October 2016

European experience with methotrexate treatment in Crohn's disease: a multicenter retrospective analysis.

Eur J Gastroenterol Hepatol 2016 Jul;28(7):802-6

aDepartment of Gastroenterology, Sheba Medical Center, Ramat Gan bSackler Medical School, Tel-Aviv University, Tel-Aviv cDepartment of Gastroenterology and Hepatology, Ben-Gurion University of the Negev, Beer Sheva, Israel dDivision of Gastroenterology, University of Ioannina, Ioannina eDepartment of Gastroenterology, Venizeleio General Hospital, Heraklion fFirst Department of Gastroenterology, Evangelismos Hospital, Athens gDepartment of Gastroenterology, University Hospital Heraklion, Crete, Greece hDepartment of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands iDepartment of Gastroenterology, Instituto de Investigacion Biomedica Ourense-Pontevedra-Vigo, Xerencia Xestion Integrada de Vigo, Spain jDepartment of Gastroenterology and Hepatology, Zvezdara University Clinical Centre, Zvezdara kMedical Faculty, University of Belgrade, Belgrade, Serbia lCentral IBD Clinic, Nicosia, Cyprus mIBD Center, Department of Gastroenterology, Humanitas Research Hospital, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MEG.0000000000000609DOI Listing
July 2016

The clinical potential of etrolizumab in ulcerative colitis: hypes and hopes.

Therap Adv Gastroenterol 2016 Jul 19;9(4):503-12. Epub 2016 May 19.

Department of Biomedical Sciences, Humanitas University, Via Manzoni 113, 20089 Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1756283X16647935DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913345PMC
July 2016

Emerging therapeutic targets and strategies in Crohn's disease.

Expert Rev Gastroenterol Hepatol 2016 Jun 16;10(6):735-44. Epub 2016 Feb 16.

a IBD Center, Department of Gastroenterology , Humanitas Research Hospital , Rozzano , Milan , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474124.2016.1142372DOI Listing
June 2016

Adalimumab for the treatment of pediatric Crohn's disease.

Expert Rev Clin Immunol 2015 27;11(9):963-72. Epub 2015 Jul 27.

Pediatric Unit, Vimercate Hospital, Vimercate, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/1744666X.2015.1072048DOI Listing
May 2016

Calcium supplementation for the prevention of colorectal adenomas: A systematic review and meta-analysis of randomized controlled trials.

World J Gastroenterol 2016 May;22(18):4594-603

Stefanos Bonovas, Gionata Fiorino, Alberto Malesci, Silvio Danese, Department of Gastroenterology, Humanitas Clinical and Research Center, 20089 Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v22.i18.4594DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858641PMC
May 2016

Preventing Collateral Damage in Crohn's Disease: The Lémann Index.

J Crohns Colitis 2016 Apr 7;10(4):495-500. Epub 2016 Jan 7.

Department of Gastroenterology, Humanitas Research Hospital, Rozzano, Milan, Italy Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ecco-jcc/jjv240DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946759PMC
April 2016

Intravenous Versus Oral Iron for the Treatment of Anemia in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Medicine (Baltimore) 2016 Jan;95(2):e2308

From the IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center, Rozzano, Milan, Italy (SB, GF, MA, SD); Humanitas University, Rozzano, Milan, Italy (SD); Department of Experimental and Health Sciences, Pompeu Fabra University, Barcelona, Spain (TL); Centre for Research in Environmental Epidemiology, Barcelona, Spain (TL); Hellenic Center for Disease Control and Prevention, Athens, Greece (TL); Laboratory of Hematology and Blood Bank Unit, "Attikon" University Hospital, School of Medicine, University of Athens, Athens, Greece (AT); and Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France (LP-B).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000002308DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718233PMC
January 2016

Integrins and adhesion molecules as targets to treat inflammatory bowel disease.

Curr Opin Pharmacol 2015 Dec;25:67-71

IBD Center, Gastroenterology, IRCCS Humanitas, Rozzano, Milan, Italy; Humanitas University, Department of Biomedical Sciences, Rozzano, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.coph.2015.11.007DOI Listing
December 2015

Progress with anti-tumor necrosis factor therapeutics for the treatment of inflammatory bowel disease.

Immunotherapy 2015 ;7(2):175-90

Department of Gastroenterology, Centro Hospitalar Vila Nova Gaia, Porto, Portugal.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt.14.105DOI Listing
November 2015

Anemia in Inflammatory Bowel Disease: The Opening of Pandora's Box?

Clin Gastroenterol Hepatol 2015 Oct 16;13(10):1767-9. Epub 2015 Jun 16.

IBD Center, Department of Gastroenterology, Humanitas Research Hospital, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2015.06.004DOI Listing
October 2015

Targeting SMAD7 in Crohn's Disease by Mongersen: Therapeutic Revolution Under Way?

Gastroenterology 2015 Oct 25;149(4):1121-3. Epub 2015 Aug 25.

Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2015.08.023DOI Listing
October 2015

Predicting future disease course in Crohn's disease by colonoscopy or magnetic resonance: which is the crystal ball?

Gut 2015 Sep 28;64(9):1347-8. Epub 2015 Jan 28.

Department of Gastroenterology, IBD Center, Humanitas Research Hospital, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/gutjnl-2014-308919DOI Listing
September 2015

Psoriasis and Inflammatory Bowel Disease: Two Sides of the Same Coin?

J Crohns Colitis 2015 Sep 15;9(9):697-8. Epub 2015 Jun 15.

Gastroenterology and Digestive Endoscopy, Humanitas Research Hospital, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ecco-jcc/jjv110DOI Listing
September 2015

State of the art: psychotherapeutic interventions targeting the psychological factors involved in IBD.

Curr Drug Targets 2014 ;15(11):1020-9

Department of Health Sciences, Università degli Studi di Milano, San Paolo University Hospital, Via di Rudinì 8, 20142 Milan, Italy.

View Article

Download full-text PDF

Source
August 2015

Catching the therapeutic window of opportunity in early Crohn's disease.

Curr Drug Targets 2014 ;15(11):1056-63

IBD Center, Department of Gastroenterology, Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
August 2015

Iron deficiency: the hidden miscreant in inflammatory bowel disease.

Curr Drug Targets 2014 ;15(11):1011-9

IBD Center, Division of Gastroenterology, IRCCS Istituto Clinico Humanitas ICH 20089, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
August 2015

Bowel Damage as Assessed by the Lémann Index is Reversible on Anti-TNF Therapy for Crohn's Disease.

J Crohns Colitis 2015 Aug 9;9(8):633-9. Epub 2015 May 9.

Department of Gastroenterology, Humanitas Research Hospital, Rozzano, Milan, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ecco-jcc/jjv080DOI Listing
August 2015

New targeted therapies such as anti-adhesion molecules, anti-IL-12/23 and anti-Janus kinases are looking toward a more effective treatment of inflammatory bowel disease.

Scand J Gastroenterol 2015 Jan;50(1):113-20

Department of Gastroenterology, Endoscopy Unit, Humanitas Research Hospital , Rozzano, Milan , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/00365521.2014.993700DOI Listing
January 2015

Etrolizumab in ulcerative colitis: tightening leukocyte traffic control in the inflamed mucosa.

Gastroenterology 2014 Dec;147(6):1433-5

IBD Center Department of Gastroenterology Humanitas Research Hospital, Rozzano Milan, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2014.10.018DOI Listing
December 2014

Viewpoint: knowledge and viewpoints on biosimilar monoclonal antibodies among members of the European Crohn's and Colitis Organization.

J Crohns Colitis 2014 Nov 6;8(11):1548-50. Epub 2014 Jul 6.

IBD Center, Gastroenterology, La Source-Beaulieu, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.crohns.2014.06.007DOI Listing
November 2014

Complementary and alternative medicine in inflammatory bowel diseases: what is the future in the field of herbal medicine?

Expert Rev Gastroenterol Hepatol 2014 Sep 12;8(7):835-46. Epub 2014 May 12.

IBD Center, Gastroenterology, IRCCS Humanitas, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474124.2014.917954DOI Listing
September 2014

The use of biosimilars in immune-mediated disease: A joint Italian Society of Rheumatology (SIR), Italian Society of Dermatology (SIDeMaST), and Italian Group of Inflammatory Bowel Disease (IG-IBD) position paper.

Autoimmun Rev 2014 Jul 19;13(7):751-5. Epub 2014 Mar 19.

Rheumatology Deparment of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.autrev.2014.02.004DOI Listing
July 2014

Blockade of lymphocyte trafficking in inflammatory bowel diseases therapy: importance of specificity of endothelial target.

Expert Rev Clin Immunol 2014 Jul 12;10(7):885-95. Epub 2014 May 12.

IBD Center, Division of Gastroenterology, IRCCS Humanitas, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/1744666X.2014.917962DOI Listing
July 2014

The biosimilar road in inflammatory bowel disease: the right way?

Best Pract Res Clin Gastroenterol 2014 Jun 4;28(3):465-71. Epub 2014 May 4.

IBD Center, Department of Gastroenterology, Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15216918140005
Publisher Site
http://dx.doi.org/10.1016/j.bpg.2014.04.006DOI Listing
June 2014

Cross-sectional imaging modalities in Crohn's disease.

Dig Dis 2013 6;31(2):199-201. Epub 2013 Sep 6.

IBD Center, Gastroenterology, IRCCS Humanitas, Rozzano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000353692DOI Listing
May 2014

Safety and efficacy of sodium hyaluronate (IBD98E) in the induction of clinical and endoscopic remission in subjects with distal ulcerative colitis.

Dig Liver Dis 2014 Apr 21;46(4):330-4. Epub 2014 Jan 21.

IBD Center, Gastroenterology, IRCCS Humanitas, Rozzano, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2013.12.008DOI Listing
April 2014

Paradoxical immune-mediated inflammation in inflammatory bowel disease patients receiving anti-TNF-α agents.

Autoimmun Rev 2014 Jan 15;13(1):15-9. Epub 2013 Jun 15.

IBD Center, IRCCS Istituto Clinico Humanitas, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.autrev.2013.06.005DOI Listing
January 2014

Preoperative magnetic resonance enterography in predicting findings and optimizing surgical approach in Crohn's disease.

J Gastrointest Surg 2014 Jan 20;18(1):83-90; discussion 90-1. Epub 2013 Nov 20.

Department of Surgery-IBD Surgery Unit, Humanitas Clinical and Research Center, via Manzoni 56, Rozzano (MI), 20089, Italy,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11605-013-2404-1DOI Listing
January 2014

Anti-IL-13 in inflammatory bowel disease: from the bench to the bedside.

Curr Drug Targets 2013 Nov;14(12):1444-52

IBD Center, Division of Gastroenterology, IRCCS Istituto Clinico Humanitas ICH 20089, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
November 2013

Anti-IL-6 treatment for inflammatory bowel diseases: next cytokine, next target.

Curr Drug Targets 2013 Nov;14(12):1508-21

IBD Center, Division of Gastroenterology, IRCCS Istituto Clinico Humanitas ICH 20089, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
November 2013

Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease--an update.

Expert Rev Clin Immunol 2013 Apr;9(4):301-6

Department of Internal Medicine and Clinical Science, Policlinico Umberto I, Rome, Italy.

View Article

Download full-text PDF

Source
http://search.proquest.com/openview/7145511dad1b71d6f8460b46
Web Search
http://www.tandfonline.com/doi/full/10.1586/eci.13.11
Publisher Site
http://dx.doi.org/10.1586/eci.13.11DOI Listing
April 2013